Orchestra BioMed Holdings (OBIO) Shares Outstanding (2020 - 2026)
Orchestra BioMed Holdings (OBIO) posted quarterly Shares Outstanding (Entity) of $58.6 million for Q1 2026, up 53.03% year-over-year from $38.3 million in Q1 2025, and up 2.8% quarter-over-quarter from $57.0 million in Q4 2025.
Orchestra BioMed Holdings (OBIO) Shares Outstanding (2020 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has reported Shares Outstanding (Entity) for 7 consecutive years, with $58.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 53.03% year-over-year to $58.6 million; the TTM figure through Mar 2026 stood at $58.6 million (up 53.03% YoY), while the FY2025 annual figure was $57.0 million, up 49.32% from the prior year.
- Shares Outstanding (Entity) rose to $58.6 million in Q1 2026 per OBIO's latest filing, from $57.0 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $58.6 million in Q1 2026 and bottomed at $13.7 million in Q3 2022.
- Historically, Shares Outstanding (Entity) has averaged $35.7 million across 5 years, with a median of $35.8 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) plunged 32.9% — and 2023, when it surged 160.48%.
- Orchestra BioMed Holdings' Shares Outstanding (Entity) stood at $16.4 million in 2022, then surged by 117.81% to $35.8 million in 2023, then climbed by 6.76% to $38.2 million in 2024, then surged by 49.32% to $57.0 million in 2025, then gained by 2.8% to $58.6 million in 2026.
- Business Quant data shows OBIO's Shares Outstanding (Entity) at $58.6 million in Q1 2026, $57.0 million in Q4 2025, and $56.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Orchestra BioMed Holdings | 265.06 Mn | 80.63 Mn | 63,000.00 | 63.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.81 Mn |
| Mar 31, 2026 | 62.72 Mn |
| Dec 31, 2025 | 47.75 Mn |
| Sep 30, 2025 | 52.19 Mn |
| Jun 30, 2025 | 38.39 Mn |
| Mar 31, 2025 | 38.24 Mn |
| Dec 31, 2024 | 36.82 Mn |
| Sep 30, 2024 | 37.62 Mn |
| Jun 30, 2024 | 35.80 Mn |
| Mar 31, 2024 | 35.78 Mn |
| Dec 31, 2023 | 33.23 Mn |
| Sep 30, 2023 | 35.24 Mn |
| Jun 30, 2023 | 34.61 Mn |
| Mar 31, 2023 | 27.64 Mn |
| Dec 31, 2022 | 16.43 Mn |
| Sep 30, 2022 | 13.72 Mn |
| Jun 30, 2022 | 20.45 Mn |
| Mar 31, 2022 | 20.45 Mn |
| Dec 31, 2021 | 20.45 Mn |
| Sep 30, 2021 | 20.45 Mn |